主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CELC
#1085
Celcuity Inc. Common Stock
111.7
1
+1.82%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.82%
每月变动
-4.66%
6个月变化
+106.53%
年变化
+1062.43%
前一天收盘价
109.7
1
Open
111.7
1
Bid
Ask
Low
111.7
1
High
111.7
1
交易量
92
市场
股票
医疗保健
CELC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
37.13 M
37.84 M
37.87 M
42.43 M
46.27 M
—
Valuation ratios
Enterprise value
541 M
472.8 M
366.35 M
520.04 M
2.21 B
3.57 B
Price to earnings ratio
-5.71
-4.63
-3.31
-3.85
-13.39
-25.17
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-3.13
-6.19
-1.64
-3.35
-53.47
-64.64
Price to book ratio
0.83
4.47
0.78
1.41
5.87
12.52
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.11
-0.76
0.17
0.25
0.09
-0.25
Return on equity %
-0.2
-1.62
0.43
1.02
0.37
0.2
Return on invested capital %
-15.36 K
-101.54 K
20.31 K
26.55 K
27.87 K
-26.81 K
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.36
7.71
6.61
4.58
12.26
31.16
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.35
0.4
0.45
0.54
0.67
2.06
Long term debt to total equity ratio
0.65
0.85
1.14
2.24
2.74
6.96
Per share metrics
Operating cash flow per share
-2.12
-3.53
0.83
0.83
0.94
-0.92
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
6.17
5.96
4.78
3.86
9.56
24.15
Net current asset value per share
6.37
6.2
5.05
4.19
9.99
25.44
Tangible book value per share
3.5
2.93
2.01
1.02
2.46
8.42
Working capital per share
5.75
5.4
4.29
3.28
9.18
22.14
Book value per share
3.5
2.93
2.01
1.02
2.46
8.42
新闻
Has Celcuity (CELC) Outpaced Other Medical Stocks This Year?
赛尔库蒂参加古根海姆峰会:生物科技创新揭秘
Celcuity at Guggenheim Summit: Biotech Innovations Unveiled
沃尔夫研究建议投资者在外部催化剂引起的弱势中买入Celcuity股票
Wolfe Research recommends buying Celcuity stock on weakness related to external catalyst
Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?
Celcuity股价创历史新高,达116.65美元
Celcuity stock hits all-time high at 116.65 USD
Celcuity Inc: A Die To Be Cast Before July 2026 (NASDAQ: CELC)
FDA accepts Celcuity’s NDA for gedatolisib with priority review
Celcuity股票创历史新高,达112.78美元
Celcuity stock reaches all-time high at 112.78 USD